Showing results (61-70 of 204) with videos related to

Sort By:
Pageof 21
The International Journal of Biological Markers|July 1, 1997
Increased blood concentrations of interleukin-12 are associated with a longer survival in untreatable metastatic solid tumor patients: preliminary observationsP Lissoni, F Rovelli, L Fumagalli, et al.
Tumori|June 30, 1994
Ondansetron does not stimulate prolactin release in breast cancer patientsP Lissoni, M Cazzaniga, F Rovelli, et al.
Controlled Clinical Trials|December 1, 1990
A linear model suitable for assessing graft patency in controlled clinical trials. SINBA GroupE Marubini, C Montoro, G Mezzanotte, et al.
The International Journal of Biological Markers|April 1, 1991
Blood levels of IGF-I in non-small cell lung cancer: relation to clinical dataE Tisi, P Lissoni, F Rovelli, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1992
Effects of granulocyte-macrophage colony stimulating factor on cortisol, growth hormone, prolactin and melatonin in cancer patients (short communication)S Crispino, P Lissoni, A Ardizzoia, et al.
The International Journal of Biological Markers|July 7, 2000
Changes in circulating dendritic cells and IL-12 in relation to the angiogenic factor VEGF during IL-2 immunotherapy of metastatic renal cell cancerA Bonfanti, P Lissoni, R Bucovec, et al.
Giornale Italiano Di Cardiologia|January 1, 1976
[The effects of verapamil on angina threshold during exercise (author's transl)]C De Ponti, R Ciliberto, G Sozzi, et al.
Circulation|November 1, 1993
Factors influencing 1-year patency of coronary artery saphenous vein grafts. Studio Indobufene nel Bypass Aortocoronarico (SINBA)G Cataldo, M Braga, N Pirotta, et al.
The International Journal of Biological Markers|November 6, 1998
Vascular endothelial growth factor (VEGF) serum levels during cancer immunotherapy with IL-2: preliminary considerationsP Lissoni, L Fumagalli, L Giani, et al.
Circulation|April 15, 1997
Activation of the hemostatic mechanism after pharmacological cardioversion of acute nonvalvular atrial fibrillationL Oltrona, M Broccolino, P A Merlini, et al.
Pageof 21